Dr. Kalika P. Sarma
Claim this profileCarle Cancer Center
Studies Breast Cancer
Studies Brain Metastasis
8 reported clinical trials
23 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
Stage II
Stage I
2Brain Metastasis
Stage IV
Affiliated Hospitals
Clinical Trials Kalika P. Sarma is currently running
Chemotherapy + Radiotherapy
for Esophageal and Gastric Cancer
This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy x-rays, gamma rays, or protons to kill tumor cells and shrink tumors. Drugs used in usual chemotherapy, such as leucovorin, 5-fluorouracil, oxaliplatin, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Adding radiotherapy to the usual chemotherapy may work better compared to the usual chemotherapy alone in treating patients with esophageal and gastric cancer.
Recruiting2 awards Phase 320 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
More about Kalika P. Sarma
Clinical Trial Related5 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Kalika P. Sarma has experience with
- Cisplatin
- Intensity-Modulated Radiation Therapy
- Fluorouracil
- Radiation Therapy
- Stereotactic Radiosurgery
- Whole-Brain Radiotherapy
Breakdown of trials Kalika P. Sarma has run
Breast Cancer
Brain Metastasis
Lung Cancer
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kalika P. Sarma specialize in?
Kalika P. Sarma focuses on Breast Cancer and Brain Metastasis. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are Stage II.
Is Kalika P. Sarma currently recruiting for clinical trials?
Yes, Kalika P. Sarma is currently recruiting for 4 clinical trials in Urbana Illinois. If you're interested in participating, you should apply.
Are there any treatments that Kalika P. Sarma has studied deeply?
Yes, Kalika P. Sarma has studied treatments such as Cisplatin, Intensity-Modulated Radiation Therapy, Fluorouracil.
What is the best way to schedule an appointment with Kalika P. Sarma?
Apply for one of the trials that Kalika P. Sarma is conducting.
What is the office address of Kalika P. Sarma?
The office of Kalika P. Sarma is located at: Carle Cancer Center, Urbana, Illinois 61801 United States. This is the address for their practice at the Carle Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.